What is GDP certification?
Good Distribution Practice (GDP) is the international standard that ensures medicines, vaccines, and healthcare products maintain their quality, identity, and integrity throughout the logistics chain. It guarantees that products arrive in optimal condition—from the manufacturer to the point of use.
R.H. Shipping is certified under the GDP (Good Distribution Practices) standard, audited in compliance with the guidelines of the World Health Organization (WHO) and the European Medicines Agency (EMA). This certification confirms that our logistics processes meet the most rigorous requirements of the pharmaceutical sector in terms of temperature control, traceability, and documentation.
Why It matters to the Pharmaceutical industry
In the healthcare industry, even the smallest deviation can cause significant losses or compromise product efficacy. GDP certification helps prevent these scenarios by ensuring that every stage of transportation is monitored, controlled, and documented.
Examples of direct impact:
-
A vaccine exceeding 8°C for more than 30 minutes can lose stability and effectiveness.
-
A dietary supplement without proper traceability records can be rejected by COFEPRIS or destination health authorities.
-
A batch of biological drugs lacking documented temperature control cannot be cleared through European customs.
GDP certification at R.H. Shipping
Holding a GDP certification means adopting a comprehensive quality and traceability management system.
Our GDP protocols include:
-
Route validation and continuous temperature monitoring across sea, air, and land transport.
-
Full documentation compliance with EMA and WHO regulations.
-
Active contingency plans for temperature deviations or transit incidents.
-
Ongoing technical training in the handling and transport of pharmaceutical products.
These procedures are periodically audited, ensuring continuous compliance and ongoing improvement.
Benefits for the industry
Partnering with a GDP-certified logistics operator provides a tangible competitive advantage for manufacturers, distributors, and exporters in the healthcare sector — including companies such as Bayer, Sanfer, J&J, and Pfizer.
Key benefits:
-
Temperature control and traceability: Prevent product loss, customs rejection, and regulatory claims.
-
Verified compliance: Processes fully aligned with EMA, WHO, and COFEPRIS standards.
-
Operational emergency plans: Reduce financial and operational risk during contingencies.
-
Regulatory simplification: A single specialized provider manages all transport and health documentation needs.
Practical cases at R.H. Shipping
Over the years, R.H. Shipping has supported various companies in the pharmaceutical, cosmetic, and healthcare sectors with logistics solutions designed under GDP principles.
Examples:
-
Air transport of insulin and plasma derivatives with continuous monitoring via validated data loggers.
-
Multimodal shipments (sea and land) of cosmetics and dietary supplements under constant temperature control.
-
National distribution of OTC products with digital traceability and full documentation at each delivery.
These projects have helped reduce logistics incidents, optimize customs release times, and ensure product integrity at every stage.
Conclusion
R.H. Shipping provides the pharmaceutical, cosmetic, and medical device industries with the assurance of operating under audited processes, total traceability, and international regulatory compliance.
Every shipment travels under total control — from origin to destination.
Where health goes, R.H. Shipping follows.
Leave a comment